Dr.Prashant Bobhate

MD(Peds), FNB (Peds Card), FPVRI.

Dr.Prashant Bobhate has an experience of 12 years in the diagnosis and management of patients with congenital heart disease. He specializes in the advanced echocardiographic evaluation and is proficient in all simple and complex cardiac catheterization interventions for congenital heart disease.

Dr.Prashant completed his basic graduation from Lokmanya Tilak Municipal medical college and postgraduation from Seth GS Medical College and KEM hospital- Mumbai. He then pursued his fellowship in pediatric cardiology from Escorts Heart Institute and Research centre-New Delhi.

Education & Training

He has pursued a Clinical fellowship in Pulmonary Hypertension at Stollery Children’s Hospital and Mazankowski Alberta Heart Institute, Edmonton, Canada.

Apart from the clinical work, his primary focus of the research was an accurate and non-invasive detection of pulmonary hypertension by advanced signal processing in the time and frequency domain using a digital stethoscope.

Book Appointment

Pulmonary Hypertension

Post his fellowship in pulmonary hypertension in Canada, Dr. Prashant set up the pulmonary hypertension clinic in KDAH. PH clinic is one of its kind in Western India, Multidisciplinary clinic involving Pulmonary hypertension specialist, Cardiologist, pediatric cardiologist, cardiac surgeons (Adult and pediatric), Rheumatologist, and Pulmonologist with one point of contact at the Children’s Heart Centre. This clinic offers comprehensive evaluation and management of patients with pulmonary hypertension. It has an extensive patient database of more than 400 patients who are registered and on regular follow up in the clinic. Apart from the routine investigation and management of patients with PH, this clinic has performed 19 Potts shunt (Highest Single-center experience in India) and has more than 15 patients on prostacyclin therapy. The clinic also has a dedicated cardiopulmonary rehabilitation center, which helps in rehab of the patients with PH.

Pediatric Cardiology

He also runs the Fetal echocardiographic clinic, where a detailed evaluation of the heart of the fetus is carried out, followed by counseling of the prospective parents.

Fetal Echocardiogram

He also runs the Fetal echocardiographic clinic, where a detailed evaluation of the heart of the fetus is carried out, followed by counseling of the prospective parents.

Breakthrough Cases

Abernathy Malformation: A rare but treatable cause of Pulmonary Hypertension

A Basic heart scan (4 chamber and outflow views) should be compulsorily done as a part of every single obstetric scan. However, certain high risk pregnancies (as detailed below) should be referred for a detail fetal echocardiography. Such high risk pregnancies should be referred at around 16-18 weeks gestation.

Potts Shunt

Creation of a connection between one of the lung arteries (Usually the left lung artery) and the body artery can help patients with severe pulmonary hypertension. Creating such a connection decreases the pressure on the right heart and thus helps it function better. We have done 19 such procedures till now with a very good success rate of more than 80%. Post the procedure most of the patients are now able to perform all their day to day activities on minimal medications. We have presented our data at various national and international conferences. Dr. Prashant Bobhate has received many awards for the same including one at the Annual European Pediatric Cardiac conference in Athens, annual conference of the Pediatric Cardiac Society of India and the Society of heart failure and transplant in Mumbai.

Use of Prostacyclin Analogues:

Prostacyclin analogues were one of the first medications to show to have mortality benefits, in patients with pulmonary hypertension. They were also the fist ones to be sanctioned by the US FDA for use in PAH. Unfortunately, these medications are still not marketed in India. Through our PH clinic we have devised a reliabel mechanism to help the patients with pulmonary hypertension, procure, and import prostacyclins. Due to our persistent efforts we now have 14 patients who are regulalry taking these medications with significant improvement in their functional capacity.